semaglutide mechanism
Stop Misreading Semaglutide’s Mechanism Today
Stop Misreading Semaglutide’s Mechanism Today About 40% of U.S. adults are eligible for GLP-1 therapy, but semaglutide acts on a single receptor while tirzepatide engages both GLP-1 and GIP pathways, creating distinct metabolic effects. Understanding these differences helps clinicians and patients set realistic expectations for weight loss and